Atlas Legacy Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Atlas Legacy Advisors's AMGN Position: Q2 2026 in Review
Atlas Legacy Advisors increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $69.8K and bringing the position to 1,644 shares worth $588K. The position accounts for 0.09% of the portfolio, ranked #130.
Atlas Legacy Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Atlas Legacy Advisors held 1,644 shares of Amgen worth $588K as of Q2 2026.
- Atlas Legacy Advisors bought 204 Amgen shares in Q2 2026, an estimated $69.8K.
- Amgen made up 0.09% of Atlas Legacy Advisors's portfolio in Q2 2026, its #130 holding.
- Atlas Legacy Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Atlas Legacy Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.